Episode 52 - Top Myopia Stories of 2025

In this episode of The Myopia Mindset, host Matthew Herzberg is joined by Dr. Ashley Tucker and Dr. Kevin Chan, co-editors of Review of Myopia Management, to break down the most important myopia management stories of 2025.From evolving clinical protocols and risk stratification models, to emerging insights into retinal neurotransmitters, dopamine pathways, and evidence-based patient communication, this episode is designed to help optometrists stay ahead of where myopia care is going — not where it’s been.If you want to grow into a confident, evidence-driven myopia management expert, this episode provides the context, nuance, and clinical relevance that matter most.The Articles discussed in this episode are from Review of Myopia Management1. https://reviewofmm.com/the-proliferation-of-myopia-management-spectacles2. https://reviewofmm.com/how-to-manage-progressive-myopia-in-young-adults3.https://reviewofmm.com/comparison-of-performance-of-myopia-control-spectacles-in-european-children4. https://reviewofmm.com/the-latest-in-red-light-therapy5. https://reviewofmm.com/retinal-neurotransmitter-systems-in-myopia-understanding-the-role-of-dopamine-and-related-pathways6. https://reviewofmm.com/the-lipson-koffler-myopia-management-treatment-protocol7. https://reviewofmm.com/20-20-20-rule/8. https://reviewofmm.com/a-wake-up-call-regulatory-changes-for-red-light-therapy-china9. https://reviewofmm.com/now-what-turning-essilors-stellest-approval-into-action/10. https://reviewofmm.com/the-economics-of-myopia-management-2/